Company Registration No. 14743510 (England and Wales)
Clera Healthcare Ltd
Unaudited accounts
for the period from 20 March 2023 to 30 June 2024
Clera Healthcare Ltd
Unaudited accounts
Contents
Clera Healthcare Ltd
Company Information
for the period from 20 March 2023 to 30 June 2024
Directors
Dr Jonathan Abeles
Dr Alice Appleton
Company Number
14743510 (England and Wales)
Registered Office
25 Ash Road 25 Ash Road
Bristol
BS7 8RN
England
Accountants
Collective Concepts Accounting Ltd
Clera Healthcare Ltd
Statement of financial position
as at 30 June 2024
Cash at bank and in hand
7,170
Creditors: amounts falling due within one year
(17,515)
Net current liabilities
(5,393)
Profit and loss account
(2,173)
Shareholders' funds
59,861
For the period ending 30 June 2024 the company was entitled to exemption from audit under section 477 of the Companies Act 2006 relating to small companies. The members have not required the company to obtain an audit in accordance with section 476 of the Companies Act 2006.
The directors acknowledge their responsibilities for complying with the requirements of the Act with respect to accounting records and the preparation of accounts.
These accounts have been prepared and delivered in accordance with the provisions applicable to companies subject to the small companies' regime and in accordance with the provisions of FRS 102 Section 1A - Small Entities. The profit and loss account has not been delivered to the Registrar of Companies.
The financial statements were approved by the Board of Directors and authorised for issue on 23 November 2024 and were signed on its behalf by
Dr Jonathan Abeles
Director
Company Registration No. 14743510
Clera Healthcare Ltd
Notes to the Accounts
for the period from 20 March 2023 to 30 June 2024
Clera Healthcare Ltd is a private company, limited by shares, registered in England and Wales, registration number 14743510. The registered office is 25 Ash Road 25 Ash Road, Bristol, BS7 8RN, England.
2
Compliance with accounting standards
The accounts have been prepared in accordance with the provisions of FRS 102 Section 1A Small Entities. There were no material departures from that standard.
These financial statements for the period from 20 March 2023 to 30 June 2024 are the first financial statements that comply with FRS 102 Section 1A Small Entities. The date of transition is 20 March 2023.
The transition to FRS 102 Section 1A Small Entities has resulted in a small number of changes in accounting policies to those used previously.
The nature of these changes and their impact on opening equity and profit for the comparative period are explained in the notes below.
The accounts have been prepared under the historical cost convention as modified by the revaluation of certain fixed assets.
The accounts are presented in £ sterling.
Tangible fixed assets and depreciation
Tangible assets are included at cost less depreciation and impairment. Depreciation has been provided at the following rates in order to write off the assets over their estimated useful lives:
Computer equipment
SLM @ 33.33%
Intangible fixed assets (including purchased goodwill and patents) are included at cost less accumulated amortisation.
Software development amortised over 10 years.
Government grants in relation to tangible fixed assets are credited to profit and loss account over the useful lives of the related assets, whereas those in relation to expenditure are credited when the expenditure is charged to profit and loss.
Salary expenditure on research and development is written off in the year in which it is incurred.
Other than salaries, expenditure on research and development is capitlised as an intangible assets in the year in which it is incurred.
Clera Healthcare Ltd
Notes to the Accounts
for the period from 20 March 2023 to 30 June 2024
4
Intangible fixed assets
Other
Charge for the period
2,927
5
Tangible fixed assets
Computer equipment
Amounts falling due within one year
7
Creditors: amounts falling due within one year
2024
Loans from directors
11,973
8
Average number of employees
During the period the average number of employees was 2.